Cibus (CBUS) Asset Utilization Ratio (2017 - 2026)

Cibus (CBUS) posted Asset Utilization Ratio of 0.01 for Q4 2025, up 2.13% sequentially from 0.01 in Q3 2025, and down 3.51% YoY from 0.01 in Q4 2024.

Cibus (CBUS) Asset Utilization Ratio (2017 - 2026) Analysis & Trends

Cibus has reported Asset Utilization Ratio for 9 years, with the latest figure at 0.01 in Q4 2025.

Quarterly Asset Utilization Ratio fell 3.51% year-over-year to 0.01 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.01 (down 3.51% YoY) and the FY2025 annual result came in at 0.01, up 16.58% from the prior year.
Asset Utilization Ratio advanced to 0.01 in Q4 2025 per CBUS's latest filing, from 0.01 in the prior quarter.
Over five years, Asset Utilization Ratio peaked at 0.87 in Q3 2021 and troughed at 0.0 in Q2 2023.
A 5-year average of 0.19 and a median of 0.01 in 2024 frame the typical range for Asset Utilization Ratio.
The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio sank 99.72% in 2023, then soared 860.33% in 2024.
Over 5 years, Asset Utilization Ratio stood at 0.68 in 2021, then plunged by 99.06% to 0.01 in 2022, then sank by 57.59% to 0.0 in 2023, then soared by 338.01% to 0.01 in 2024, then retreated by 3.51% to 0.01 in 2025.
According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.01, 0.01, and 0.01 for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	138.71 Bn	130.86 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	85.60 Bn	77.60 Bn	3.93 Bn	0.38
3	Argenx Se	64.82 Bn	59.63 Bn	1.37 Bn	-
4	Moderna	57.92 Bn	52.79 Bn	52.00 Mn	0.20
5	BeOne Medicines	41.88 Bn	36.78 Bn	1.53 Bn	0.69
6	Alnylam Pharmaceuticals	31.46 Bn	28.15 Bn	992.69 Mn	0.90
7	BioNTech SE	27.96 Bn	9.57 Bn	668.28 Mn	0.13
8	Insmed	27.35 Bn	26.19 Bn	358.27 Mn	0.54
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.13
10	Cibus	131.64 Mn	111.21 Mn	-	0.01

Download Data